StockData
Zimmer Biomet Holdings, Inc. logo

Zimmer Biomet Holdings, Inc. (ZBH) stock

ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3018% below fair value
$102.09+0.68 (+0.67%)

Close on Nov 17, 2026Market cap $19.47BP/E 24.8Yield 0.94%

Zimmer Biomet cash

Cash and short-term investments held at the end of each period.

Zimmer Biomet's cash was $410.00M at Jun 30, 2026. For fiscal 2025 it was $591.90M, up 12.6% from the year before. Over ten years it grew -9.6% a year on average. The highest annual figure on record is $1.81B in fiscal 2013.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$591.90M+12.6%
FY2024Dec 31, 2024$525.50M+26.4%
FY2023Dec 31, 2023$415.80M+10.7%
FY2022Dec 31, 2022$375.70M-0.6%
FY2021Dec 31, 2021$378.10M-52.9%
FY2020Dec 31, 2020$802.10M+29.8%
FY2019Dec 31, 2019$617.90M+13.8%
FY2018Dec 31, 2018$542.80M+3.5%
FY2017Dec 31, 2017$524.40M-17.3%
FY2016Dec 31, 2016$634.10M-61.0%
FY2015Dec 31, 2015$1.62B-4.2%
FY2014Dec 31, 2014$1.70B-6.2%
FY2013Dec 31, 2013$1.81B+16.2%
FY2012Dec 31, 2012$1.56B+27.1%
FY2011Dec 31, 2011$1.22B+31.0%
FY2010Dec 31, 2010$934.00M+23.2%
FY2009Dec 31, 2009$758.10M+256.6%
FY2008Dec 31, 2008$212.60M-54.2%
FY2007Dec 31, 2007$463.90M+74.6%
FY2006Dec 31, 2006$265.70M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$410.00M-26.4%
Q1 FY2026Mar 31, 2026$424.20M-69.4%
Q4 FY2025Dec 31, 2025$591.90M+12.6%
Q3 FY2025Sep 30, 2025$1.29B+127.2%
Q2 FY2025Jun 30, 2025$556.90M+32.6%
Q1 FY2025Mar 31, 2025$1.38B+252.3%
Q4 FY2024Dec 31, 2024$525.50M+26.4%
Q3 FY2024Sep 30, 2024$569.00M+94.8%
Q2 FY2024Jun 30, 2024$420.10M+31.4%
Q1 FY2024Mar 31, 2024$393.00M+19.0%
Q4 FY2023Dec 31, 2023$415.80M+10.7%
Q3 FY2023Sep 30, 2023$292.10M-46.4%
Q2 FY2023Jun 30, 2023$319.80M-17.2%
Q1 FY2023Mar 31, 2023$330.20M-24.2%
Q4 FY2022Dec 31, 2022$375.70M-0.6%
Q3 FY2022Sep 30, 2022$545.40M-40.7%
Q2 FY2022Jun 30, 2022$386.40M-62.9%
Q1 FY2022Mar 31, 2022$435.80M-39.8%
Q4 FY2021Dec 31, 2021$378.10M-52.9%
Q3 FY2021Sep 30, 2021$919.60M-4.9%
Q2 FY2021Jun 30, 2021$1.04B+46.1%
Q1 FY2021Mar 31, 2021$724.30M-70.2%
Q4 FY2020Dec 31, 2020$802.10M+29.8%
Q3 FY2020Sep 30, 2020$967.30M+88.7%
Q2 FY2020Jun 30, 2020$713.40M+77.0%
Q1 FY2020Mar 31, 2020$2.43B+314.7%
Q4 FY2019Dec 31, 2019$617.90M+13.8%
Q3 FY2019Sep 30, 2019$512.50M-2.3%
Q2 FY2019Jun 30, 2019$403.10M-16.2%
Q1 FY2019Mar 31, 2019$586.80M-66.8%
Q4 FY2018Dec 31, 2018$542.80M+3.5%
Q3 FY2018Sep 30, 2018$524.60M+9.1%
Q2 FY2018Jun 30, 2018$481.20M+6.9%
Q1 FY2018Mar 31, 2018$1.77B+69.8%
Q4 FY2017Dec 31, 2017$524.40M-17.3%
Q3 FY2017Sep 30, 2017$480.80M-1.6%
Q2 FY2017Jun 30, 2017$450.00M–
Q1 FY2017Mar 31, 2017$1.04B–
Q4 FY2016Dec 31, 2016$634.10M–
Q3 FY2016Sep 30, 2016$488.70M–

More Zimmer Biomet figures

See a number that looks wrong?